- $22.81m
- -$23.30m
- $63.46m
- 46
- 63
- 83
- 69
Annual income statement for Moatable, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | R2022 December 31st | R2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 20-F | 20-F | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 18.1 | 32.2 | 45.8 | 52.1 | 63.5 |
Cost of Revenue | |||||
Gross Profit | 14.7 | 25.4 | 35.4 | 40.9 | 48.3 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 45.3 | 53.2 | 106 | 63.9 | 67.1 |
Operating Profit | -27.2 | -21 | -60.6 | -11.8 | -3.65 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -16.9 | -45.4 | -67.4 | -15.5 | -3.39 |
Provision for Income Taxes | |||||
Net Income After Taxes | -16.9 | -44.4 | -65 | -8.78 | -2.53 |
Minority Interest | |||||
Equity in Affiliates | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -19.2 | 13.7 | -76.9 | -10.1 | -2.14 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -19.2 | 13.7 | -76.9 | -10.1 | -2.14 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.013 | -0.093 | -0.042 | -0.009 | -0.002 |